Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Kroiss

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 1, 2021
[Hormones and The Heart - Clinical Cases]Carmina Teresa Fuss, Matthias Kroiss, Stefanie Hahner, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|July 6, 2020
Next-generation therapies for adrenocortical carcinomaBarbara Altieri, Cristina L Ronchi, Matthias Kroiss, et al.
Hormones & Cancer|September 16, 2016
Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma CellsMatthias Kroiss, Silviu Sbiera, Sabine Kendl, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 13, 2020
Correction: Steroidogenesis in the NCI-H295 Cell Line Model is Strongly Affected By Culture Conditions and SubstrainMax Kurlbaum, Silviu Sbiera, Sabine Kendl, et al.
Macromolecular Bioscience|October 10, 2019
A Micellar Mitotane Formulation with High Drug-Loading and Solubility: Physico-Chemical Characterization and Cytotoxicity Studies in 2D and 3D In Vitro Tumor ModelsMalik Salman Haider, Jochen Schreiner, Sabine Kendl, et al.
European Journal of Endocrinology|April 10, 2014
EJE prize 2014: current and evolving treatment options in adrenocortical carcinoma: where do we stand and where do we want to go?Cristina L Ronchi, Matthias Kroiss, Silviu Sbiera, et al.
The Journal of Clinical Endocrinology and Metabolism|August 20, 2021
Reassessment of Postural Stimulation Testing as a Simple Tool to Identify a Subgroup of Patients With Unilateral Primary AldosteronismCarmina Teresa Fuss, Katharina Brohm, Martin Fassnacht, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 30, 2020
Steroidogenesis in the NCI-H295 Cell Line Model is Strongly Affected By Culture Conditions and SubstrainMax Kurlbaum, Silviu Sbiera, Sabine Kendl, et al.
Clinical Endocrinology|September 3, 2011
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinomaMatthias Kroiss, Marcus Quinkler, Werner K Lutz, et al.
Analytical and Bioanalytical Chemistry|May 17, 2019
A method for the minimally invasive drug monitoring of mitotane by means of volumetric absorptive microsampling for a home-based therapeutic drug monitoringBettina Friedl, Max Kurlbaum, Matthias Kroiss, et al.
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
Deutsche Medizinische Wochenschrift (1946)|March 1, 2021
[Hormones and The Heart - Clinical Cases]Carmina Teresa Fuss, Matthias Kroiss, Stefanie Hahner, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|July 6, 2020
Next-generation therapies for adrenocortical carcinomaBarbara Altieri, Cristina L Ronchi, Matthias Kroiss, et al.
Hormones & Cancer|September 16, 2016
Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma CellsMatthias Kroiss, Silviu Sbiera, Sabine Kendl, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 13, 2020
Correction: Steroidogenesis in the NCI-H295 Cell Line Model is Strongly Affected By Culture Conditions and SubstrainMax Kurlbaum, Silviu Sbiera, Sabine Kendl, et al.
Macromolecular Bioscience|October 10, 2019
A Micellar Mitotane Formulation with High Drug-Loading and Solubility: Physico-Chemical Characterization and Cytotoxicity Studies in 2D and 3D In Vitro Tumor ModelsMalik Salman Haider, Jochen Schreiner, Sabine Kendl, et al.
European Journal of Endocrinology|April 10, 2014
EJE prize 2014: current and evolving treatment options in adrenocortical carcinoma: where do we stand and where do we want to go?Cristina L Ronchi, Matthias Kroiss, Silviu Sbiera, et al.
The Journal of Clinical Endocrinology and Metabolism|August 20, 2021
Reassessment of Postural Stimulation Testing as a Simple Tool to Identify a Subgroup of Patients With Unilateral Primary AldosteronismCarmina Teresa Fuss, Katharina Brohm, Martin Fassnacht, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 30, 2020
Steroidogenesis in the NCI-H295 Cell Line Model is Strongly Affected By Culture Conditions and SubstrainMax Kurlbaum, Silviu Sbiera, Sabine Kendl, et al.
Clinical Endocrinology|September 3, 2011
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinomaMatthias Kroiss, Marcus Quinkler, Werner K Lutz, et al.
Analytical and Bioanalytical Chemistry|May 17, 2019
A method for the minimally invasive drug monitoring of mitotane by means of volumetric absorptive microsampling for a home-based therapeutic drug monitoringBettina Friedl, Max Kurlbaum, Matthias Kroiss, et al.
Pageof 18